凝血因子检测在重症肝病中临床应用.docVIP

凝血因子检测在重症肝病中临床应用.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
凝血因子检测在重症肝病中临床应用

凝血因子检测在重症肝病中临床应用   [摘要] 目的 探讨凝血因子在重症肝病临床诊断中的意义。方法 选利用BE Compact全自动血凝仪比色法,对选取的60例患者凝血因子的活性水平进行检测,并选取50例健康人,对其饮血因子活性进行检测作为对照组,与其进行对比。 结果 经检测发现,60例患者凝血因子的活性水平明显低于50例健康人凝血因子的活性水平。因此,对凝血因子活性水平测定,可以更及时、更准确地为诊断重症肝病提供有效参考依据,提高预后。 结论 凝血因子活性测定有利于重症肝病的诊断,其可作为肝脏合成的可靠指标。对其进行测定也可全面了解重症肝病患者凝血因子缺乏的程度,以及判断肝功能损害程度,并可采取有效措施进行预防,其对临床诊治重症肝病和指导用药具有重要意义,能有效提高患者预后。   [关键词] 凝血因子检测;重症肝病;临床应用   [中图分类号] R725 [文献标识码] A [文章编号] 1674-0742(2015)02(a)-0054-02   Detection of Clotting Factor in Severe Liver Disease in Clinical Application   ZHANG Xiuhui   The first peoples hospital in shenyang Clinical Laboratory Shengyang City in Liaoning Province,110041,China   [Abstract] Objective Explore clotting factors in the diagnosis of severe liver disease clinical significance. Methods Choose use BE Compact fully automatic blood coagulation instrument colorimetric method, selection of 60 cases of patients with blood clotting factor activity level testing, and 50 cases of healthy people, to test the its drinking blood factor activity as the control group, comparing with. Results After testing found that the activity of clotting factor levels of 60 patients significantly lower than the activity of 50 cases of healthy human clotting factor levels. Level determination of activity of clotting factors, therefore, can be more timely, more accurate to provide effective reference for diagnosis of severe liver diseases, improve the prognosis. Conclusion Clotting factor activity determination is helpful for the diagnosis of severe liver disease, which can be used as a reliable indicator of liver. To measure can also be a comprehensive understanding of the extent of severe liver disease patients lack of clotting factors, judging and liver function damage degree, and can take effective measures to prevent, its guidance to the clinical treatment of severe liver disease and drug use is of great significance, can effectively improve the prognosis of patients.   [Key words] Lotting factor detection; Severe liver dis

文档评论(0)

erterye + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档